A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens-Reference-Cited by-同舟云学术

A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens

Published:2017-02 Issue:2 Volume:7 Page:e529-e529
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Baccelli I,Krosl J,Boucher G^ORCID,Boivin I,Lavallée V-P,Hébert J,Lemieux S,Marinier A,Sauvageau G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201710.pdf

Reference41 articles.

1. Lin TL, Levy MY . Acute myeloid leukemia: focus on novel therapeutic strategies. Clin Med Insights Oncol 2012; 6: 205–217.

2. Siegel RL, Miller KD, Jemal A . Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7–30.

3. Showel MM, Levis M . Advances in treating acute myeloid leukemia. F1000prime Rep 2014; 6: 96.

4. Tefferi A, Letendre L . Going beyond 7+3 regimens in the treatment of adult acute myeloid leukemia. J Clin Oncol 2012; 30: 2425–2428.

5. Yates JW, Wallace HJ Jr, Ellison RR, Holland JF . Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep 1973; 57: 485–488.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic targeting of surfaceome heterogeneity in AML;Cell Reports;2024-06

2. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in AML;2022-01-27

3. Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia;Blood Advances;2022-01-18

4. Cu/Pd‐Catalyzed One‐Pot Synthesis of 2‐(1,2,3‐Triazolyl)methyl‐3‐alkynylImidazo[1,2‐ a ]pyridines Involving Sequential SN Reaction/[3+2] Cycloaddition/Sonogashira Coupling Reactions;ChemistrySelect;2021-09-15

5. Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues;RSC Advances;2020